Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10007 |
| Vaccine Name | Abdala |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Protein subunit |
| Vaccine Status | Approved |
| Manufacturer | Center for Genetic Engineering and Biotechnology |
| Year of Manufacturing | 2021 |
| Manufacturing Country | Cuba |
| Age | 19 - 80 years |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | Aluminum (aluminium hydroxide) |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | Cuba Drug Regulator |
| Collaborating Organisation | NA |
| Other Countries | Cuba, Venezuela |
| Trade Name | CIGB-66 |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://rpcec.sld.cu/en/trials/RPCEC00000363-En |
| Additional Links | https://rpcec.sld.cu/en/trials/RPCEC00000359-En |